Human parainfluenza viruses
Parainfluenza virus 1; 2; 3; 4
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
RNA viruses causing respiratory infection; types 1 and 2 cause croup in children and type 3 causes bronchiolitis and pneumonia.
Infections
Croup, bronchiolitis, pneumonia, upper respiratory infection.
Signs and symptoms
Barking cough and stridor in children; cold-like symptoms or pneumonia in adults.
Antibiotic and antimicrobial resistance
No antiviral is used, so drug resistance is not a clinical issue. Antibiotics do not act on viruses; identifying a viral cause can support withholding them.
Treatment considerations
Supportive care. Croup in children is treated with a corticosteroid and, when severe, nebulized epinephrine. No antiviral is approved; antibiotics are not indicated without a bacterial complication.
Infection control and public health
Contact and droplet precautions.

Sources
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.